Prasad’s Request To Remain Anonymous Shines Light on FDA’s Transparency Problem

While requests by government officials for anonymity when speaking to the media are nothing new, the practice attracts more scrutiny when the Department for Health and Human Services has pledged a commitment to “radical transparency.”

Scroll to Top